SPRINT issues final report finding fewer cardiovascular events with intensive blood pressure control
Patients treated to a systolic blood pressure target less than 120 mm Hg instead of less than 140 mm Hg had lower rates of cardiovascular events but more incidence of some adverse events, according to new follow-up data.
25 May 2021
Missing an adult diagnosis of attention deficit hyperactivity disorder (ADHD) means patients also miss out on effective, often life-changing treatment.
1 Apr 2023
Compared to other NSAIDs, celecoxib and meloxicam were associated with a lower risk of bleeding or cardiovascular events among Korean patients who had a myocardial infarction (MI).
28 Jul 2020
A retrospective study found that gout patients who experienced an acute myocardial infarction or stroke had significantly higher odds of a recent gout flare in the preceding four months than those who did not.
9 Aug 2022
Cardiovascular events similar, adverse effects worse with chlorthalidone compared to hydrochlorothiazide
Chlorthalidone was associated with a significantly higher risk of hypokalemia, hyponatremia, acute renal failure, chronic kidney disease, type 2 diabetes, and abnormal weight gain.
25 Feb 2020
Home measurement of high blood pressure overcomes variability inherent in office measurements, delivers better assessment of systolic pressure (and hence, of possible cardiovascular events) and offers a better chance of discontinuing drug therapy.
1 Mar 2011
A Danish study also found that more men with ischemic heart disease are taking both nitrates and a phosphodiesterase type 5 (PDE5) inhibitor, with the prescription rate increasing 20-fold from 2000 to 2018.
19 Apr 2022
Primary care physicians' efforts are paying off as they promote primary prevention of cardiovascular disease, even in a time-pressed visit.
1 Feb 2022
Risk for myocardial infarction, unstable angina, acute ischemic heart disease, ischemic stroke, percutaneous coronary intervention, coronary artery bypass graft, and cardiac arrest was higher in patients whose prescription for a PCSK9 inhibitor was denied or abandoned.
30 Jul 2019
Patients who continued aspirin had a 4.1% yearly incidence of cardiovascular events, compared to 5.4% among those who stopped taking the drug, while the risk of discontinuation corresponded to one additional cardiovascular event for every 74 patients who stopped taking aspirin in a year.
3 Oct 2017